Prospects for tuberculosis elimination
- PMID: 23244049
- DOI: 10.1146/annurev-publhealth-031912-114431
Prospects for tuberculosis elimination
Abstract
The target for TB elimination is to reduce annual incidence to less than one case per million population by 2050. Meeting that target requires a 1,000-fold reduction in incidence in little more than 35 years. This can be achieved only by combining the effective treatment of active TB-early case detection and high cure rates to interrupt transmission-with methods to prevent new infections and to neutralize existing latent infections. Vigorous implementation of the WHO Stop TB Strategy is needed to achieve the former, facilitated by the effective supply of, and demand for, health services. The latter calls for new technology, including biomarkers of TB risk, diagnostics, drugs, and vaccines. An important milestone en route to elimination will be reached when there is less than 1 TB death per 100,000 population, marking entry into the elimination phase. This landmark can be reached by many countries within 1-2 decades.
Similar articles
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination.Eur Respir J. 2013 Sep;42(3):785-801. doi: 10.1183/09031936.00205512. Epub 2013 Feb 8. Eur Respir J. 2013. PMID: 23397299
-
Stopping tuberculosis in the 21st century: goals and strategies.Respirology. 2010 Jan;15(1):32-43. doi: 10.1111/j.1440-1843.2009.01673.x. Respirology. 2010. PMID: 20199633 Review.
-
Low access to a highly effective therapy: a challenge for international tuberculosis control.Bull World Health Organ. 2002;80(6):437-44. Bull World Health Organ. 2002. PMID: 12131999 Free PMC article.
-
Tuberculosis control and elimination 2010-50: cure, care, and social development.Lancet. 2010 May 22;375(9728):1814-29. doi: 10.1016/S0140-6736(10)60483-7. Lancet. 2010. PMID: 20488524
Cited by
-
Strategic investment in tuberculosis control in the Republic of Bulgaria.Epidemiol Infect. 2019 Nov 18;147:e304. doi: 10.1017/S0950268819001857. Epidemiol Infect. 2019. PMID: 31736454 Free PMC article.
-
Bayesian modeling of spatiotemporal patterns of TB-HIV co-infection risk in Kenya.BMC Infect Dis. 2019 Oct 28;19(1):902. doi: 10.1186/s12879-019-4540-z. BMC Infect Dis. 2019. PMID: 31660883 Free PMC article.
-
Clinic presentation delay and tuberculosis treatment outcomes in the Lake Victoria region of East Africa: A multi-site prospective cohort study.PLOS Glob Public Health. 2023 Aug 30;3(8):e0002259. doi: 10.1371/journal.pgph.0002259. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37647287 Free PMC article.
-
Transforming the fight against tuberculosis: targeting catalysts of transmission.Clin Infect Dis. 2014 Oct 15;59(8):1123-9. doi: 10.1093/cid/ciu506. Epub 2014 Jun 30. Clin Infect Dis. 2014. PMID: 24982034 Free PMC article. Review.
-
Correcting the record on BCG before we license new vaccines against tuberculosis.J R Soc Med. 2017 Nov;110(11):428-433. doi: 10.1177/0141076817732965. Epub 2017 Sep 26. J R Soc Med. 2017. PMID: 28949270 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials